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TWO-ELECTRON DONATING 
PHENOTHIAZINES AND USE THEREOF 
2 
aqueous electrolytes. Only a handful of organic electroactive 
materials are capable of dissolving at concentrations greater 
than 0.5M.7·9 
PRIORITY Accordingly, there exists a need for stable electroactive 
5 
materials having sufficient atom economy for use in non-
This invention claims priority to U.S. Provisional Appli-
cation Ser. No. 62/378,443, filed Aug. 23, 2016. 
aqueous redox flow batteries. 
GOVERNMENT INTEREST SUMMARY OF INVENTION 
10 
This invention was made with govermnent support under 
grant numbers 1300653 and 1355438 awarded by the 
National Science Foundation. The government has certain 
rights in the invention. 
TECHNICAL FIELD 
The presently-disclosed subject matter includes com-
pounds that can be used stable two-electron redox-active 
materials. The presently-disclosed subject matter further 
15 
includes rechargeable batteries, including non-aqueous 
redox flow batteries and the use of two-electron redox-active 
materials as electrolytic materials. 
The presently-disclosed subject matter generally relates to 
phenothiazine derivatives. In particular, certain embodi-
ments of the presently-disclosed subject matter relate to 
phenothiazine derivatives having stable first and second 
oxidation states and the use thereof for redox flow batteries. 
In some embodiments of the presently-disclosed subject 




Redox flow batteries (RFBs ), which function by storing 
electrochemical energy in liquid electrolyte formulations, 
are promising technologies for energy storage on medium to 
large scales. 1 Since the energy is stored in a liquid form, 
increasing the capacity of RFBs is largely a matter of 30 
increasing the size of active-material storage tanks. Current 
state-of-the-art RFBs are based upon aqueous vanadium 
chemistry. While such RFBs are robust and long-lived, they 
rely upon expensive transition metals as active materials that 
form redox active species. Additionally, these RFBs are 35 
aqueous-based and, therefore, are limited by the electro-
chemical stability window of water (about 1.5 V).2 
One possibility for accessing higher voltages includes the 
use of non-aqueous electrolytes, which are generally not 
compatible with transition metal-based active materials. 40 
Although such systems have the potential for increasing the 
voltage of the system and reducing cost by exchanging 
scarce transition metals for plentiful carbon-based materials, 
the development and commercialization of organic non-
aqueous redox flow batteries is largely in its infancy due to 45 
challenges in long term stability,3 atom economy,4 and 
solubility/energy density. 5 
For example, due to stability requirements for extended 
periods of time in both neutral and oxidized forms, only a 
limited number of molecular classes have been used for 50 
catholyte (positive electrolyte) material in preliminary all-
organic non-aqueous RFBs, including dialkoxybenzenes6 , 
stabile N-oxo radicals 7, and phenothiaizines. 8 •9 These mol-
ecules are electron rich and are therefore capable of donating 
an electron when paired with an anolyte (negative electro- 55 
lyte) material. However, molecules used as charge storage 
materials must also function with excellent atom economy. 
Vanadium-based aqueous RFBs have excellent atom 
economy with the ability to store an electron with 50 amu of 
mass. Organic materials, on the other hand, generally have 60 
molecular weights of about 150-300 amu due to need for 
stabilizing structures to allow for reversible electrochemical 
performance. This presents a challenge for organic non-
aqueous systems as this represents a 65-85% reduction in 
atom economy relative to vanadium. Related to the 65 
increased molecular weights of organic materials are the 
lower concentrations of active species achieved in non-
In some embodiments, R1 and R2 are independently selected 
from H, N(R')2 , N(R")2 , OR', OR", and R" so long as when 
R1 is H, R2 is not H. In some instances, R, R' and R" are 
independently selected from alkyl, aryl, alkylaryl, alkox-
yaryl, alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroal-
kyl, glycol, polyether, haloaryl, a negative electrolyte, a 
polymerizable unit, and a polymer. 
In some embodiments, the compound is an N-substituted 
phenothiazine with a structure represented by: 
US 10,954,201 B2 
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FIG. 2 is a schematic showing synthesis ofN-substituted 
3, 7-dimethoxyphenothiazine derivatives. 
FIG. 3 is a graph showing cyclic voltammograms of 
DMeOEPT, DMeOMEPT, and DMeOMEEPT in PC/LiBF 4 . 5 
FIG. 4 is a graph showing UV-vis spectra monitored at 
various potentials for a solution ofDMeOEPT at 0.375 mM 
in a spectroelectrochemical cell containing Pt honeycomb 
electrode card and a freshly anodized Ag/ AgCl electrode in 
10 0.lM LiTFSI in PC. 
FIG. 5 shows graphs illustrating DMeOEPT half-cell 
cycling accessing only the first oxidation state (left) and both 
first and second oxidations (right). 
15 FIG. 6 shows graphs illustrating DMeOMEPT half-cell 
cycling accessing only the first oxidation state (left) and both 
first and second oxidations (right). 
FIG. 7 shows graphs illustrating DMeOMEEPT half-cell 
cycling accessing only the first oxidation state (left) and both 
20 first and second oxidations (right). 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
The details of one or more embodiments of the presently-
disclosed subject matter are set forth in this document. 
Modifications to embodiments described in this document, 
In some embodiments, the N-substituted phenothiazine 
compounds presently disclosed include one or more solu-
25 
bilizing groups tethered to the phenothiazine core via a 
linkage at the N-position, also denoted as the 10 position. 
The solubilizing group tethered to the phenothiazine core 
can, in some instances, increase solubility of the compound 
30 
and other embodiments, will be evident to those of ordinary 
skill in the art after a study of the information provided in 
this document. The information provided in this document, 
and particularly the specific details of the described exem-
plary embodiments, is provided primarily for clearness of 
in organic electrolytes. \ 
In some embodiments, the N-substituted phenothiazine 
compounds contain one or more electron-donating func-
tional groups attached at the 3 and/or 7 position. Suitable 
electron-donating functional groups include, but are not 
limited to, alkoxy groups, amino groups, or a combination 35 
thereof. In some embodiments, substituents can be posi-
tioned at the 1, 2, 4, 6, 8, and/or 9 positions as long as there 
is an alkoxy group and/or amino group and/or other suitable 
electron-donating functional group at the 3 and/or 7 posi-
tions. Specifically, the minimum number of substituents the 40 
present inventors have demonstrated that is needed is at the 
3, 7, and 10 (or 3, 7, and N; N is the same as 10). It is 
contemplated that the 3 and 10 (N) positions can enable the 
second charge to be stabilized. 
In some embodiments, compounds disclosed herein find 45 
use in non-aqueous redox flow batteries. In some instances, 
the non-aqueous redox flow battery includes a negative 
electrode immersed in a first non-aqueous liquid electrolyte 
solution; a positive electrode immersed in a second non-
aqueous liquid electrolyte solution, with the second non- 50 
aqueous liquid electrolyte solution including a compound as 
disclosed herein; and a semi-permeable separator interposed 
between the negative and positive electrodes. 
DESCRIPTION OF THE DRAWINGS 
The novel features of the invention are set forth with 
particularity in the appended claims. A better understanding 
of the features and advantages of the present invention will 
55 
be obtained by reference to the following detailed descrip- 60 
tion that sets forth illustrative embodiments, in which the 
principles of the invention are used, and the accompanying 
drawings of which: 
FIG. 1 is a graph showing cyclic voltammograms of 
DMeOEPT, DMeOMEPT, and DMeOMEEPT, performed 65 
with 10 mM analyte in 0.5M LiPF 6 in PC at a scan rate of 
100 mV/s. 
understanding and no unnecessary limitations are to be 
understood therefrom. In case of conflict, the specification of 
this document, including definitions, will control. 
The presently-disclosed subject matter includes N-substi-
tuted phenothiazine compounds. The phenothiazine forms a 
redox-active core of the N-substituted phenothiazine com-
pounds. In some embodiments, one or more solubilizing 
groups may be tethered to the phenothiazine core via a 
linkage at the N-position. The solubilizing group tethered to 
the phenothiazine core increases solubility of the compound 
in organic electrolytes. Additionally or alternatively, in some 
embodiments, the N-substituted phenothiazine compounds 
contain one or more electron-donating functional groups 
attached at the 3 and/or 7 position. Suitable electron-donat-
ing functional groups include, but are not limited to, alkoxy 
groups, amino groups, or a combination thereof. 
For example, in some embodiments, the N-substituted 
phenothiazine compound includes an alkoxyphenothiazine 
according to the formula set forth below: 
wherein R is an alkyl or (poly)ether and R' is an alkyl. 
In some embodiments, the N-substituted phenothiazine 
compound includes a dialkoxyphenothiazine according to 
the formula set forth below: 
US 10,954,201 B2 
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wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl, 10 
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, gly-
col, polyether, haloaryl, a negative electrolyte, a polymer-
izable unit, and a polymer, and R' is selected from alkyl, aryl, 
alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloal- 15 
kyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative 
electrolyte, a polymerizable unit, and a polymer. 
In some embodiments, the N-substituted phenothiazine 
compound includes a monoaminophenothiazine according 20 
to the formula set forth below: 
wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl, 
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, gly-
wherein R, R', and R" are independently selected from alkyl, 
aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, 
25 haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a 
negative electrolyte, a polymerizable unit, and a polymer. 
Furthermore, in some embodiments of the compound, 
substituents can be positioned at the 1, 2, 4, 6, 8, and/or 9 
30 
positions as long as there is an alkoxy group and/or amino 
group at the 3 and/or 7 positions. Specifically, the minimum 
number of substituents the present inventors have demon-
strated that is needed is at the 3, 7, and 10 (or 3, 7, and N; 
N is the same as 10). It is contemplated that the 3 and 10 (N) 
col, polyether, haloaryl, a negative electrolyte, a polymer- 35 
positions can enable the second charge to be stabilized. 
"Alkyl" refers to a saturated or unsaturated, branched, 
straight-chain or cyclic monovalent hydrocarbon radical 
derived by the removal of one hydrogen atom from a single 
carbon atom of a parent alkane, alkene or alkyne. Typical 
izable unit, and a polymer, and R' is selected from alkyl, aryl, 
alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloal-
kyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative 
electrolyte, a polymerizable unit, and a polymer. 
In some embodiments, the N-substituted phenothiazine 
compound includes a diaminophenothiazine according to 
the formula set forth below: 
wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl, 
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, gly-
col, polyether, haloaryl, a negative electrolyte, a polymer-
40 alkyl groups include, but are not limited to, methyl; ethyls 
such as ethanyl, ethenyl, ethynyl; propyls such as propan-
1-yl, propan-2-yl, cyclopropan-1-yl, prop-1-en-1-yl, prop-
l-en-2-yl, prop-2-en-1-yl (ally!), cycloprop-1-en-1-yl; 
cycloprop-2-en-1-yl, prop-1-yn-1-yl, prop-2-yn-1-yl, etc.; 
45 butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-1-yl, 
2-methyl-propan-2-yl, cyclobutan-1-yl, but-l-en-1-yl, but-
l-en-2-yl, 2-methyl-prop-1-en-1-yl, but-2-en-1-yl, but-2-en-
2-yl, buta-1,3-dien-1-yl, buta-1,3-dien-2-yl, cyclobut-l-en-
50 1-yl, cyclobut-l-en-3-yl, cyclobuta-1,3-dien-1-yl, but-1-yn-
l-yl, but-l-yn-3-yl, but-3-yn-1-yl, etc.; and the like. 
Preferably, an alkyl group comprises from 1 to 20 carbon 
atoms, more preferably, from 1 to 10 carbon atoms. 
"Ary!" refers to a monovalent aromatic hydrocarbon 
55 radical derived by the removal of one hydrogen atom from 
a single carbon atom of a parent aromatic ring system. 
Typical aryl groups include, but are not limited to, groups 
derived from aceanthrylene, acenaphthylene, ace-
izable unit, and a polymer, and R' is selected from alkyl, aryl, 
60 
alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloal-
phenanthrylene, anthracene, azulene, benzene, chrysene, 
coronene,fluoranthene,fluorene,hexacene,hexaphene,hex-
alene, as-indacene, s-indacene, indane, indene, naphthalene, 
kyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative 
electrolyte, a polymerizable unit, and a polymer. 
In some embodiments, the N-substituted phenothiazine 65 
compound is according to any one of the following formu-
lae: 
octacene, octaphene, octalene, ovalene, penta-2,4-diene, 
pentacene, pentalene, pentaphene, perylene, phenalene, 
phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubi-
cene, triphenylene, trinaphthalene and the like. Preferably, 
an aryl group comprises from 6 to 20 carbon atoms, more 
preferably, between 6 to 12 carbon atoms. 
US 10,954,201 B2 
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"Alkylaryl" refers to an acyclic alkyl in which one of the 
hydrogen atoms bonded to a carbon atom, is replaced with 
an aryl group. Typical arylalkyl groups include, but are not 
limited to, benzyl, 2-phenylethan-1-yl, 2-phenylethen-1-yl, 
naphthylmethyl, 2-naphthylethan-1-yl, 2-naphthylethen-1- 5 
yl, naphthobenzyl, 2-naphthophenylethan-1-yl and the like. 
Where specific alkyl moieties are intended, the nomencla-
ture arylalkanyl, arylalkenyl and/or arylalkynyl is used. 
Preferably, an arylalkyl group is (CcC30) arylalkyl, e.g., the 
alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is 10 
(C1 -C10) and the aryl moiety is (C6 -C20), more preferably, an 
arylalkyl group is (CcC20) arylalkyl, e.g., the alkanyl, 
alkenyl or alkynyl moiety of the arylalkyl group is (C1 -C8 ) 
and the aryl moiety is (C6-C12). 
"Alkoxyaryl" refers to an ---0-arylalkyl where arylalkyl 
is as defined herein. 
"Alkylcarboxyl" means a -C(O)R group where R is 
alkyl, as defined herein. 




"Halogen" or "halo" refers to fluorine, chlorine, bromine 
and iodine. Thus, a haloalkyl, refers to an alkyl group 
substituted with one or more halogens. A halo aryl refers to 25 
an aryl group substituted with one or more halogens. 
"Perfluoroalkyl" refers to alkyl groups in which essen-
tially all of the carbon-bonded hydrogen has been replaced 
by fluorine. 30 
"Polyether" refers to a functional group containing more 
than one ether, which can include aromatic polyethers such 
as polyphenyl ether. 
Glycols include alcohols in which at least two hydroxyl 
35 
groups are attached to different carbon atoms in an organic 
compound, including alkylene glycols such as ethylene 
glycol and propylene glycol. 
A negative electrolyte can include, for example, LiBF 4 , 
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D(MEEO)MEEPT 
In contrast to most phenothiazines, which decompose in 
the second oxidation state, the introduction of electron-
donating functional groups to the phenothiazine redox-
active core facilitates a reversible second oxidation event 
A polymer consist of a large number of repeating units 
bonded together. A polymerizable unit, in some instances, 
can be a monomer, oligomer, or low molecular weight 
polymer that is capable of being polymerized upon activa-
tion. 45 and/or formation of a doubly oxidized species that is stable 
for extended periods of time. Accordingly, in some embodi-
ments, the N-substituted phenothiazine compounds 
described herein provide stable two-electron redox-active 
In some embodiments, the N-substituted phenothiazine 
compounds have stable first and second oxidation states 
(e.g., radical cation, dication). For example, suitable N-sub-
stituted phenothiazine compounds having stable first and 
50 
second oxidation states include, but are not limited to, 
two-electron donor compounds having the structure: 
R 
h:Q I~ 
MeO S # OMe 
wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl, 
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, gly-
col, polyether, haloaryl, a negative electrolyte, a polymer-
izable unit, and a polymer. 
In one embodiment, the two-electron donor compounds 




materials. For example, as illustrated in FIG. 1 and Table 1, 
the dimethoxy-substituted phenothiazine derivatives, such 
as compounds I-IV shown above, provide stable first and 
second oxidations occurring at about 3.4 and 3.9 V vs. Li, 
respectively. 
TABLE 1 
Measured half-wave first and second oxidation potentials and 
diffusion coefficients. 
Diffusion 
Compound 1" Eox vs. Li (VJ" 2nd Eox vs. Li (VJ" Coefficient 
3.38 3.94 0.8/0.8 
II 3.42 3.96 1.0/0.9 
III 3.41 3.98 0.5/0.5 
N 
acyclic voltammetry was performed with 10 mM analyte in 0.5M LiPF6 in PC at a scan 
rate of 100 mV/s. 
US 10,954,201 B2 
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With regard to Compound IV, oxidation potentials are 
0.035 V and 0.625 V vs. ferrocenium/ferrocene in 0.5M 
TEATFSI/acetonitrile. 
In certain embodiments, the stable first and second oxi-
dations facilitate formation of stable dications in non-aque-
ous electrolytes without requiring an extensive increase 
(e.g., doubling) of molecular weight. By forming stable 
dications without extensive increases in molecular weight, 
the N-substituted phenothiazine compounds described 
herein provide increased atom economy (i.e., molecular 
weight per electron). Such atom utilization can be advanta-
geous for both efficiency of the chemical processes and 
contribute to a greener chemistry process. In one embodi-
ment, for example, the N-substituted phenothiazine com-
pounds described herein increase atom economy by up to 
100% as compared to existing compounds and/or catholytes. 
Additionally, in some embodiments, the N-substituted 
phenothiazine compounds described herein provide 
increased solubility in electrolyte formulations as compared 
to existing compounds, such as 2,5-di-tert-butyl-1,4-bis(2-
methoxyethoxy)benzene (DBBB). In one embodiment, the 
glyme substituents provide increased solubility in electro-
lyte formulations as compared to other derivatives. For 
example, as compared to the N-ethyl derivative, which 
exhibited a solubility of about 100 mM, the glyme and 
diglyme derivatives exhibited higher solubility while retain-
ing stable redox chemistry. In another embodiment, this 
solubility in organic solvents permits the use of renewable 
earth-abundant elements. 
In some embodiments, the N-substituted phenothiazine 
compounds described herein provide a multi-electron donor 
including high stability and solubility in catholyte formula-
tions. In another embodiment, the catholyte material pro-
vides a multi-electron donor that retains high chemical 
stability when charged. In a further embodiment, as catho-
lyte energy density is limited due to solubility, stability, and 
redox chemistry, the high solubility, ability to act as a 
multi-electron donor, and/or high chemical stability of the 
compounds described herein significantly increases volu-
metric energy density as compared to other catholyte mate-
rials. For example, when formulated at its solubility limit, 
diglyme-dimethoxyphenothiazine may provide approxi-
mately 5 times the volumetric energy of DBBB, which has 
an energy density of 10 Ah/L when formulated as a catho-
lyte, and is limited by its solubility (0.4M) and redox 
chemistry, acting as a single electron donor. 
The presently-disclosed subject matter also includes a 
method of making an N-substituted phenothiazine deriva-
tive. As illustrated in FIG. 2, in some embodiments, the 
method includes synthesizing an N-substituted phenothiaz-
ine according to previously reported procedures ( e.g., 
Odom, 2014 and Kaur, 2015), forming a 3,7-dibromophe-
nothiazine derivative through aromatic dibromination, and 
then forming a 3,7-dimethoxyphenothiazine derivative 
through methoxylation of the dibromophenothiazine. In one 
embodiment, the methoxylation includes treatment with 
sodium methoxide and copper (I) iodide in refluxing pyri-
dine. Non-limiting examples of process conditions are pro-
vided below in Examples 1-3. In some embodiments, the 
reactions are scalable. 
The presently-disclosed subject matter also includes a 
non-aqueous redox flow battery. In some embodiments, the 
non-aqueous redox flow battery includes a negative elec-
trode immersed in a first non-aqueous liquid electrolyte 
solution, a positive electrode immersed in a second non-
aqueous liquid electrolyte solution, and a semi-permeable 
separator interposed between the negative and positive elec-
10 
trodes. In one embodiment, the second non-aqueous liquid 
electrolyte solution includes one or more of the N-substi-
tuted phenothiazine compounds described herein. For 
example, in another embodiment, the one or more N-sub-
5 stituted phenothiazine compounds form the electro-active 
material for the catholyte of the non-aqueous redox flow 
batteries. In other embodiments, the presently disclosed 
invention includes a positive cell comprising a cathode and 
a catholyte including one or more of the N-substituted 
10 phenothiazine compounds described herein. 
In certain embodiments, the one or more N-substituted 
phenothiazine compounds include two electron-donating 
groups per phenothiazine, which approximately doubles 
15 
electrode capacity, increases atom economy in redox flow 
batteries, and/or decreases battery cost as compared to 
phenothiazine compounds having one electron-donating 
group. 
The presently disclosed subject matter is also directed to 
20 making a non-aqueous redox flow battery. The method of 
making a non-aqueous redox flow battery includes immers-
ing a negative electrode in a first non-aqueous liquid elec-
trolyte solution, immersing a positive electrode in a second 
non-aqueous liquid electrolyte solution, and interposing a 
25 semi-permeable separator between the negative and positive 
electrodes. The second non-aqueous liquid electrolyte solu-
tion including one or more of the N-substituted phenothi-
azine compounds described herein. 
The non-aqueous liquid electrolyte solution of the pres-
30 ently-disclosed non-aqueous redox flow battery comprises 
an organic solvent, which can be selected, for example, from 
a carbonate solvent, a nitrile, an ether, an aromatic com-
pound, and an ester. Examples of appropriate carbonate 
solvents include, but are not limited to propylene carbonate, 
35 ethylene carbonate, ethyl methylcarbonate, diethylcarbon-
ate, and dimethylcarbonate. Examples of appropriate nitriles 
include, but are not limited to acetonitrile, 1,4-dicyanobu-
tane, 1,6-dicyanohexane. Examples of appropriate ethers 
include, but are not limited to diethylether, ether, 1,4-
40 dioxane, diethylene glycol diethyl ether, ethyl ether, and 
tetrahydrofuran. Examples of aromatic compounds include, 
but are not limited to, benzene, toluene, pentene, xylenes, 
chlorobenzene, anisole, and 1,2-dichlorobenzene. An 
example of a glycol includes, but is not limited to, trieth-
45 ylene glycol. Examples of esters include, but are not limited 
to, ethyl acetate. Other solvents are described, for example, 
in R. M. Darling et al., Pathways to low cost electrochemical 
energy storage: a comparison of aqueous and nonaqueous 
flow batteries, Energy Environ, Sci., 2014, 7, 3459-3477, 
50 incorporated by reference in its entirety. 
In some embodiments, the solvent is a polar solvent. Polar 
organic solvents include, but are not limited to, acetonitrile, 
acetone, tetrahydrofuran, acetic acid, acetyl acetone, 2-ami-
noethanol, aniline, anisole, benzene, benzonitrile, benzyl 
55 alcohol, 1-butanol, 2-butanol, i-butanol, 2-butanone, t-butyl 
alcohol, carbon disulfide, carbon tetrachloride, chloroben-
zene, chloroform, cyclohexanol, cyclohexanone, di-n-
butylphthalate, 1, 1-dichloroethane, dichloroethane, diethyl-
amine, diethylene glycol, diglyme, dimethoxyethane 
60 (glyme), N,N-dimethylaniline, N,N-dimethylformamide 
(DMF), dimethylphthalate, dimethylsulfoxide (DMSO), 
dioxane, ethanol, ethyl acetate, ethyl acetoacetate, ethyl 
benzoate, ethylene glycol, heptane, hexane, methanol, 
methyl acetate, methyl t-butyl ether (MTBE), methylene 
65 chloride, 1-octanol, 1-pentanol, 2-pentanol, 3-pentanol, 
2-pentanone, 3-pentanone, 1-propanol, 2-propanol, pyri-
dine, and tetrahydrofuran(THF). 
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including, but not limited thereto, diethyl phosphate, bro-
mide, iodide, chloride, methylsulfate, dodecylbenzene-
sulfonate, trimethylpentyl)phosphinate, dicyanamide, 
decanoate, triflate, bis(trifluoromethylsulfonyl)imide, 1,1,2, 
5 2-tetrafluoroethanesulfonate, perfluorobutanesulfonate, 
In other embodiments, the non-aqueous liquid is an ionic 
liquid. When an ionic liquid is used in a non-aqueous 
system, this is preferably an inorganic salt made of the 
combination of cations including, but not limited thereto, 
ammonium, immidazolium, piperidinium, pyrrolidinium, 
phophosium and sulfonium cations with anions including, 
but not limited thereto, diethyl phosphate, bromide, iodide, 
chloride, methylsulfate, dodecylbenzenesulfonate, trimeth-
ylpentyl)phosphinate, dicyanamide, decanoate, triflate, bis 
(trifluoromethylsulfonyl)imide, 1, 1,2,2-tetrafluoroethane- 10 
sulfonate, perfluorobutanesulfonate, hexafluorophosphates, 
tetrafluoroborates, sulphate, sulfonate, phosphate, thiocya-
nate, dicyanamide, acetate, trifluoroacetate, nitrate, tetra-
chloroferrate, tetrathiocyanocobaltate and methylcarbonate. 
hexafluorophosphates, tetrafluoroborates, sulphate, 
sulfonate, phosphate, thiocyanate, dicyanamide, acetate, tri-
fluoroacetate, nitrate, tetrachloroferrate, tetrathiocyanoco-
baltate and methylcarbonate. 
In some embodiments, the metal halide salt comprises a 
cation such as, for example, Li+ and Na+. In some embodi-
ments, the metal halide salt comprises anions such as, for 





-, B(C2 O4 )
2
-, and B12X6Hc12-n/-, 
The non-aqueous redox flow batteries of the presently 
disclosed invention include a semi-permeable separator. 
Non-limiting examples of suitable separator materials 
include sulfonated tetrafluoroethylene-based fluoropolymer-
copolymers, such as NAFION® type ion exchange mem-
branes, sulfonated poly( ether ether ketones ), polysulfones, 
polyethylene, polypropylene, ethylene-propylene copoly-
mers, polyimides, polyvinyldifluorides, and the like, which 
can be in the form of membranes, matrix-supported gels, 
sheets, films, or panels. Other suitable materials include 
porous ceramics, porous insulated metals, cation-conducting 
glasses, and zeolites. Other porous films, panels or mesh will 
be readily understood by those skilled in the art. 
15 wherein X is a halogen. 
The electrodes utilized according to the invention can 
include metal, a carbon material, or a combination thereof. 
Examples include platinum, copper, aluminum, nickel or 
stainless steel, acetylene black, carbon black, activated car-
20 bon, amorphous carbon, graphite, graphene, or a nanostruc-
tured carbon material, or a combination thereof. The elec-
trode can be porous, fluted, or smooth. 
In some instances the redox flow battery includes the 
redox flow battery shown in U.S. Patent Application Publi-
25 cation No. 2013/0224538 to Jansen et al., which is incor-
porated herein by this reference. 
The compounds used in the non-aqueous redox flow 
battery has high solubility. In some embodiments, the com-
pound has a solubility of about 0.5M or greater. In some 30 
embodiments, the compound has a solubility of about I .OM 
or greater. In some embodiments, the compound has a 
solubility of about 2.0M or greater. In some embodiments, 
the compound has a solubility of about 3.0M or greater. In 
some embodiments, the compound has a solubility of about 35 
4.0M or greater. In some embodiments, the compound has a 
solubility of about 5.0M or greater. In some embodiments, 
the compound has a solubility in the non-aqueous liquid 
electrolyte solution of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 
1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 40 
2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 
4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, or 5.0M. The 
high solubility of the compounds disclosed herein in con-
junction with the non-aqueous redox flow battery provides a 
higher capacity battery that can be used in commercial 45 
applications. 
In some embodiments, the electro-active compound is 
part of a polymer. In this regard, the relative concentration 
of electro-active moiety can be described, rather than that of 
the entire polymer chain. For example, if a repeat unit of 50 
1,000 monomers was included, then the concentration of 
monomer can be described, instead of the concentration the 
polymer chain, because in that case, the concentration of 
polymer would be about 1 000x lower than the concentration 
In some instances, the non-aqueous redox flow battery 
provides stability over about 500 cycles, 600 cycles, 700 
cycles, 800 cycles, 900 cycles or 1000 cycles or more. 
While the terms used herein are believed to be well 
understood by those of ordinary skill in the art, certain 
definitions are set forth to facilitate explanation of the 
presently-disclosed subject matter. Unless defined other-
wise, all technical and scientific terms used herein have the 
same meaning as is commonly understood by one of skill in 
the art to which the invention(s) belong. 
Where reference is made to a URL or other such identifier 
or address, it understood that such identifiers can change and 
particular information on the internet can come and go, but 
equivalent information can be found by searching the inter-
net. Reference thereto evidences the availability and public 
dissemination of such information. 
As used herein, the abbreviations for any protective 
groups, amino acids and other compounds, are, unless 
indicated otherwise, in accord with their common usage, 
recognized abbreviations, or the IUPAC-IUB Commission 
on Biochemical Nomenclature (see, Biochem. (1972) 11(9): 
1726-1732). 
Although any methods, devices, and materials similar or 
equivalent to those described herein can be used in the 
practice or testing of the presently-disclosed subject matter, 
representative methods, devices, and materials are described 
herein. 
Following long-standing patent law convention, the terms 
of electro-active moiety. 55 "a", "an", and "the" refer to "one or more" when used in this 
application, including the claims. In some embodiments, the non-aqueous electrolyte solu-
tion comprises a metal halide salt. Non-limiting examples of 
the metal halide salt include LiBF 4 , NaBF 4 , LiPF 6 , NaPF 6 , 
lithium bis( oxalato )borate, tetra-n-butylammonium hexa-
fuorophosphate tetra-n-butylammonium bromide, tetra-n- 60 
butylammonium tetrafluoroborate. In some embodiments, 
the electrolyte solution can include an ionic liquid dissolved 
in an organic solvent. The ionic liquid dissolved in the 
organic solvent can be, for example, an inorganic salt made 
of the combination of cations including, but not limited 65 
thereto, ammonium, immidazolium, piperidinium, pyrroli-
dinium, phophosium and sulfonium cations with anions 
Unless otherwise indicated, all numbers expressing quan-
tities of ingredients, properties such as reaction conditions, 
and so forth used in the specification and claims are to be 
understood as being modified in all instances by the term 
"about". Accordingly, unless indicated to the contrary, the 
numerical parameters set forth in this specification and 
claims are approximations that can vary depending upon the 
desired properties sought to be obtained by the presently-
disclosed subject matter. 
As used herein, the term "about," when referring to a 
value or to an amount of mass, weight, time, volume, 
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concentration or percentage is meant to encompass varia-
tions of in some embodiments ±20%, in some embodiments 
±10%, in some embodiments ±5%, in some embodiments 
±1%, in some embodiments ±0.5%, and in some embodi-
ments ±0.1 % from the specified amount, as such variations 5 
are appropriate to perform the disclosed method. 
14 
equipped with a Pt honeycomb electrode card, used as the 
working and the counter electrode and a freshly anodized 
Ag/AgCl electrode, used as the reference electrode. UV-vis 
spectra were obtained on an Agilent 8453 diode array 
spectrometer and electrochemical analysis was performed 
using a CH Instruments 650E potentiostat. First a UV-vis 
spectrum and a cyclic voltammogram was recorded on the 
sample. Bulk electrolysis (with coulometery) was then per-
formed for 1 min at 0.1 V increments from 0 to 1.5 V and 
As used herein, ranges can be expressed as from "about" 
one particular value, and/or to "about" another particular 
value. It is also understood that there are a number of values 
disclosed herein, and that each value is also herein disclosed 
as "about" that particular value in addition to the value itself. 
For example, if the value "10" is disclosed, then "about 10" 
is also disclosed. It is also understood that each unit between 
10 then back to 0 V; followed by a UV-vis measurement at each 
of those potentials. The chosen potential window was 
obtained from cyclic voltammogram measurement. 
two particular units are also disclosed. For example, if 10 
and 15 are disclosed, then 11, 12, 13, and 14 are also 15 
disclosed. 
EXAMPLES 
Materials and Methods for Examples 1-3. 20 
Hexanes, diethyl ether, and ethyl acetate were Macron 
brand purchased from VWR. Copper (I) iodide (98%) was 
purchased from Acros Organics. Magnesium sulfate was 
purchased from Fisher Scientific. Anhydrous methanol 
(99.8%), anhydrous pyridine (99.8%), and sodium were 25 
purchased from Sigma-Aldrich. Silica gel (65x250 mesh) 
was purchased from Sorbent Technologies. 1H and 13C 
NMR spectra were obtained on Varian spectrometers in 
DMSO-d6 from Cambridge Isotope Laboratories. Propylene 
carbonate and LiPF 6 were battery grade and purchased from 30 
BASF Corporation (Florham Park, N.J.). 
Dimethoxy-Substitutedphenothiazine Derivative Synthe-
sis: 
Example 1: Preparation of 
3, 7 -dimethoxy-N-ethyl-phenothiazine 
N-Ethy 1-phenothiazine and 3, 7 -dibromo-N-ethy 1-phe-
nothiazine were prepared by previously reported procedures. 
Odom, 2014 and Kaur, 2015. 
3, 7 -dimethoxy-N-ethyl-phenothiazine 
Sodium methoxide (-5M in methanol) solution was pre-
pared by dissolving 0.25 g sodium (9.6 mmol) in 2.0 mL 
methanol in a round bottom flask at 0° C. under a N 2 
atmosphere. To the resultant methoxide solution, Cul (763 
mg, 4.01 mmol), 3,7-dibromo-N-ethyl-phenothiazine (383 
g, 1.00 mmol), and pyridine (5 mL) were added. The 
reaction mixture was sparged with dry nitrogen for 15 
minutes. A reflux condenser was attached and the reaction 
was heated at 120° C. for 12 hours. Upon completion of the 
reaction, the reaction mixture was diluted with diethyl ether 
and washed with brine. The organic extracts were dried over 
magnesium sulfate, filtered and concentrated under reduced Dimethoxy-substituted phenothiazine derivatives were 
prepared in two steps from previously synthesized N-sub-
stituted phenothaizines (FIG. 2). In the first step, aromatic 
dibromination lead selectively to the 3,7-dibromophenothi-
azine derivatives. Methoxylation of the dibromophe-
nothaizines was afforded by treatment with sodium methox-
ide and copper (I) iodide in refluxing pyridine. This reaction 
afforded the desired products in 45-91 % yield. DMeOEPT 
(R=CH2CH3 ) and DMeOMEPT (R=CH2CH2 OCH3 ) were 
isolated as white crystalline solids, while DMeOMEEPT 
(R=(CH2 CH2O)2CH3 ) was isolated as a colorless oil. The 
products were characterized by lH and 13C NMR, mass 
spectrometry, melting point (if crystalline), elemental analy-
sis and single crystal x-ray diffraction (if crystalline) to 
confirm identity and purity. 
35 pressure. The organic residue was purified by silica gel 
chromatography using 0-10% ethyl acetate in hexane as 
eluent to afford the product as a white crystalline solid (264 
mg) in 91 % yield. The product was further recrystallized 
from aqueous methanol solution. 1H NMR (DMSO-d6 , 400 
40 MHz, ppm) Ii 6.88-6.90 (m, 2H), 6.75-6.77 (m, 4H), 3.79 (q, 
J=6.8 Hz, 2H), 3.33 (s, 6H), 1.24 (t, J=6.8 Hz, 3H), 13C 
NMR (DMSO-d6 , 100 MHz, ppm) Ii 154.5, 138.4, 124.3, 
115.9, 112.9, 112.4, 55.4, 41.1, 12.8. GCMS: m/z 287 
(41 %), 258 (100%), 215 (18%).Anal. calcd. forC 16H17NOS 
45 C, 66.87; H, 5.96; N, 4.87. Found C, 66.70; H, 5.94; N, 4.95. 
Electrochemical Analysis: 
The cyclic voltammetry experiments illustrated in FIG. 3 50 
were performed with a CH Instruments 650E potentiostat 
using a three-electrode system with glassy carbon as the 
working electrode, Li metal as the reference electrode, and 
a Pt wire as a counter electrode. Each solution contained 10 
mM analyte and 0.5M LiBF 4 in PC. Voltammograms were 55 
recorded at a scan rate of 100 mV/s. Oxidation potentials are 
reported relative to Li+m_ 
Spectroelectrochemistry: 
The results of spectroelectrochemical measurements on 
0.375 mM DMeOEPT in 0.lM LiTFSI in PC are illustrated 60 
Melting point: 115-116° C. (aq. MeOH). 
Example 2: Preparation of 
3, 7 -dimethoxy-N-methoxyethy 1-phenothiazine 
3, 7-dibromo-N-methoxyethyl-phenothiazine 
N-methoxyethyl-phenothiazine (0.251 g, 0.973 mmol) 
was dissolved in DMF (3 mL). The reaction mixture was 
cooled in an ice bath and N-bromosuccinimide (0.397 g, 
2.23 mmol) was added portion-wise over 10 minutes. The 
reaction was allowed to warm to room temperature and 
stirred overnight. Upon completion of the reaction, the 
reaction mixture was diluted with ethyl acetate and washed 
with water, sodium thiosulfate solution and brine. The 
organic extracts were dried over magnesium sulfate, filtered 
and concentrated under reduced pressure. The organic resi-
due was purified by silica gel chromatography using 0-10% 
ethyl acetate in hexane as eluent to afford the product as a 
in FIG. 4. These data show that two distinct species are 
formed at each oxidation event, further supporting the 
formation of a radical cation, then a dication, in two separate 
events, rather than one two-electron-transfer event. Spectro-
electrochemical measurements were performed using the 
spectroelectrochemical cell kit obtained from Pine research. 
1 mL of the sample solution was placed in the quartz cuvette 
65 white crystalline solid (332 mg) in 82% yield. The product 
was further recrystallized from ethanol solution. 1 H NMR 
(DMSO-d6 , 400 MHz, ppm) Ii 7.36 (m, 4H), 6.99 (m, 2H), 
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4.01 (t, 1=5.6 Hz, 2H), 3.61 (t, 1=5.6 Hz, 2H), 3.24 (s, 3H). 
13C NMR (DMSO-d6 , 100 MHz, ppm) Ii 143.6, 130.3, 
129.0, 125.2, 117.5, 114.2, 68.6, 58.2, 47.0. GCMS: m/z 
413/415/417 (61%), 368/370/372 (100%), 354/356/358 
(22%), 336/338/340 (24%), 289/291 (42%), 196 (26%). 5 
Anal. calcd. for C15H13NOSBr2 C, 43.40; H, 3.16; N, 3.37. 
Found C, 43.45; H, 2.98; N, 3.25. Melting point: 88-89° C. 
(EtOH). 
16 
methanol. To the methoxide solution, Cul (1.65 g, 8.68 
mmol), DiBrMEEPT (1.00 g, 2.17 mmol) and pyridine (10.8 
mL) were added. The reaction mixture was purged with 
nitrogen for 15 minutes. A reflux condenser was attached 
and the reaction was heated at 120° C. for 12 hours. Upon 
completion of the reaction, the reaction mixture was diluted 
with diethyl ether and washed with brine. The organic 
extracts were dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The organic residue 3, 7-dimethoxy-N-methoxyethy 1-phenothiazine 
A concentrated sodium methoxide solution was prepared 
by dissolving 0.13 g sodium (5.7 mmol) in 2 mL methanol. 
To the methoxide solution, Cul ( 461 mg, 2.42 mmol), 
3,7-dibromo-N-methoxyethyl-phenothiazine (0.249 g, 0.599 
mmol) and pyridine (3 mL) were added. The reaction 
mixture was sparged with nitrogen for 15 minutes. A reflux 
condenser was attached and the reaction was heated at 120° 
10 was purified by silica gel chromatography using 40% ethyl 
acetate in hexane as eluent to afford the product as a 
colorless syrup (350 mg) in 45% yield. 1 H NMR (DMSO-d6 , 
400 MHz, ppm) Ii 6.93 (dt, 2H, 1=9.2, 1.4), 6.76 (m, 4H), 
3.93 (t, 2H, 1=5.6), 3.69 (s, 6H), 3.68 (t, 2H, 1=5.6), 3.52 (m, 
15 2H), 3.41 (m, 2H), 3.21 (s, 3H). 13C NMR (DMSO-d6 , 100 
MHz, ppm) ll 154.7, 138.5, 124.6, 116.1, 112.9, 112.4, 71.2, 
69.6, 67.5, 58.0, 55.4, 47.3. GCMS: m/z 361 (77%), 272 
(100%), 258 (78%), 240 (60%), 215 (26%), 172 (12%). 
Anal. calcd. for C19H23NO4 S C, 63.14; H, 6.41; N, 3.88. 
C. for 12 hours. Upon completion of the reaction, the 
reaction mixture was diluted with diethyl ether and washed 
with brine. The organic extracts were dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. 
The organic residue was purified by silica gel chromatog-
raphy using 0-10% ethy I acetate in hexane as eluent to afford 
the product as a white crystalline solid (132 mg) in 69% 
yield. The product was further recrystallized from ethanol 25 
solution. 1H NMR (DMSO-d6 , 400 MHz, ppm) Ii 6.92 (m, 
2H), 6.75 (m, 4H), 3.93 (t, 1=5.6 Hz, 2H), 3.69 (s, 6H), 3.59 
20 Found C, 63.16; H, 6.55; N, 3.90. 
(t, 1=5.6 Hz, 2H), 3.24 (s, 3H). 13C NMR (DMSO-d6 , 100 
MHz, ppm) ll 154.7, 138.5, 124.6, 116.1, 112.9, 112.4, 69.0, 
58.2, 55.4, 47.0. GCMS: m/z 317 (100%), 272 (100%), 258 
(86%), 240 (73%), 215 (22%), 172 (13%). Anal. calcd. for 30 
C17H19NO3 S C, 64.33; H, 6.03; N, 4.41. Found C, 64.46; H, 
6.01; N, 4.45. Melting point: 108-110° C. (EtOH). 
Example 3: Preparation of 3,7-dimethoxy-N-((2-
methoxy )ethoxy )ethy 1-phenothiazine 
3, 7-dibromo-N-( (2-methoxy )ethoxy )ethylphenothi-
azme 
35 
Example 4: Preparation of D(MEEO)MEEPT 
( 
pyridine, 120° C., 
reflux 24 h 
I~ fXNn Br S # Br 
( 
1" fXNV 'o/'-...../0 -...../'-o s ~ o/'-...../0 -...../'-o/ 
An oven-dried 1 L round-bottomed flask was transferred 
to an argon filled glove box, then diethylene glycol monom-
N-((2-methoxy)ethoxy)ethylphenothiazine (1.12 g, 3.73 
mmol) was dissolved in anhydrous dichloromethane (DCM) 
40 ethyl ether (390 mL, 3.41 mo!) was added into the round-
bottomed flask and removed it from the glove box. Freshly 
cut sodium metal (9.562 g, 415.5 mmol) was dissolved in 
diethylene glycol monomethyl ether under nitrogen atmo-
sphere. Then, copper (i) iodide (31.65 g, 168.2 mmol), 
(11 mL) in a round-bottomed flask. The reaction mixture 
was cooled in an ice bath and N-bromosuccinimide (2.0 g, 
11.2 mmol) was added portion-wise over 10 minutes. The 
reaction was allowed to stir at 0° C. for 30 min. Upon 
completion of the reaction, the reaction mixture was 
quenched with sodium thiosulfate, diluted with DCM, and 
then the organic layer washed with water and brine. The 
organic extracts were dried over magnesium sulfate, filtered 
and concentrated under reduced pressure. The organic resi-
due was purified by silica gel chromatography using 40% 50 
ethyl acetate in hexane as eluent to afford the product as a 
pale red syrup (1.03 g) in 60% yield. 1H NMR (DMSO-d6 , 
400 MHz, ppm) Ii 7.35 (m, 4H), 7.00 (dd, 2H, 1=6.8, 2.8), 
4.00 (t, 2H, 1=5.6), 3.69 (t, 2H, 1=5.6), 3.51 (m, 2H), 3.40 
(m, 2H), 3.19 (s, 3H). 13C NMR (DMSO-d6 , 100 MHz, 55 
ppm) ll 144.1, 130.8, 129.5, 125.7, 118.1, 114.6, 71.7, 70.1, 
67.6, 58.5, 47.8. GCMS: m/z 457/459/461 (63%), 368/370/ 
372 (100%), 354/356/358 (25%), 336/338/340 (16%), 289/ 
291 (31%), 207 (18%), 196 (26%). Anal. calcd. for 
C17H17NO2 SBr2 C, 44.47; H, 3.73; N, 3.05. Found C, 44.61; 60 
H, 3.74; N, 3.05. 
3, 7-dimethoxy-N-((2-methoxy )ethoxy)ethyl-phe-
nothiazine 
Sodium methoxide (-3M in methanol) solution was pre-
pared by dissolving 0.50 g sodium (22 mmol) in 7 mL 
45 3,7-dibromo-N-ethylphenothiazine (16.00 g, 41.55 mmol) 
and anhydrous pyridine (320 mL) were added to the resul-
tant solution. After that reaction mixture was sparged with 
nitrogen about 15 min while stirring. The round-bottomed 
flask was immersed in an oil bath and heated to 120° C. for 
overnight after connecting a reflux condenser. Upon comple-
tion of the reaction, reaction mixture was concentrated by 
using rotovap. Then reaction mixture was diluted with ethyl 
acetate and washed with IM aq. HCI, water and brine. The 
combined organic extracts were dried over magnesium 
sulphate and concentrated by using rotary evaporation. 
Finally, organic residue was purified on a silica gel column 
using 20-50% ethyl acetate in hexanes. The silica gel was 
neutralized with trimethylamine (2-3 mL) during packing 
the colunm. The product was yellow/light red viscous liquid 
(14.8 g, 77%). A saturated solution of D(MEEO)EPT-BF 4 
salt in DCM was prepared. A small volume was transferred 
in a NMR tube and carefully layered it with toluene to form 
two distinct layers. Finally, the NMR tube was capped and 
placed in a freezer, and crystals formed at the interface of the 
65 solvents. 1H NMR (DMSO-d6 , 400 MHz, ppm)) ll 6.90-6.85 
(m, 2H), 6.79-6.75 (m, 4H), 4.05-3.98 (m, 4H), 3.79 (q, 
1=6.9 Hz, 2H), 3.71-3.65 (m, 4H), 3.58-3.52 (m, 4H), 
US 10,954,201 B2 
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3.47-3.41 (m, 4H), 3.23 (s, 6H), 1.23 (t, 1=6.9 Hz, 3H). 13C 
NMR ((DMSO-d6 , 100 MHz, ppm) Ii 153.91, 138.66, 
124.47, 116.02, 113.79, 113.31, 71.47, 69.88, 69.14, 67.81, 
58.26, 41.33, 12.93. GCMS: m/z 463 (100%), 434 (30%), 
360 (11%), 230 (14%), 103(18%), 59(47%).Anal. calcd. for 5 
C24H33NO6 S C, 62.18; H, 7.18; N, 3.02; 0, 20.71; S, 6.92. 
Found C, 62.40; H, 7.22; N, 3.03. 
Discussion of Examples: 
Preliminary experiments to determine the stability of 
dialkoxyphenothiazines on longer timescales were accom- 10 
plished by half-cell cycling experiments versus lithium 
metal. Active material was dissolved at 0.01M in 0.5M 
LiBF 4 /PC and soaked into a graphite felt electrode. A 2032 
coin cell was assembled with the graphite felt, a lithiated 
15 
Nafion membrane and lithium metal. For one-electron trans-
fer reactions, the coin cell was cycled between 3.1 and 3.6 
V. All three dialkyoxybenzene shows high stability in one-
electron cycling with high coulombic efficiency (>95% over 
100 cycles) and little loss of active material over 100 cycles 20 
(FIGS. 5-7). Such performance suggests that the first oxi-
dation state of these compounds is highly stable and does not 
react or decompose leading to decreased capacities. Cross-
over and premature reaction of the oxidized species at the 
lithium anode may account for the small loss in coloumbic 25 
efficiency. 
For two-electron transfer reactions, the coin cell was 
cycled between 3.1 and 4.2 Vin order to access the second 
oxidation state of the dialkoxyphenothiazines. Roughly 
twice the capacity of the one-electron experiment is 30 
observed but with reduced coulombic efficiency (about 
80-90% ). The reduced coulombic efficiency is likely due to 
extended charging times leading to increased membrane 
crossover and premature reduction of the active material. 
Little loss of active material is observed which is promising 35 
as it again suggests that the material is stable in its second 
oxidation state form. Additionally, as shown by the cyclic 
voltammetry experiments discussed above (FIG. 3), both 
first and second oxidation events were reversible and were 
observed at about 3.4 V and 4.0 V for all three compounds. 40 
All patents, patent applications, publications, and other 
published materials mentioned in this specification, unless 
noted otherwise, are herein incorporated by reference to the 
same extent as if each individual publication, patent, or 
patent application was specifically and individually indi- 45 
cated to be incorporated by reference, including the refer-
ences set forth in the following list: 
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5. Wei, X.; Cosimbescu, L.; Xu, W.; Hu, J. Z.; Vijayakumar, 
M.; Feng, J.; Hu, M. Y.; Deng, X.; Xiao, J.; Liu, J.; 
Sprenkle, V.; Wang, W. Adv. Energy Mater. 2015, 5, 
1400678. 
6. Huang, J.; Cheng, L.; Assary, R. S.; Wang, P.; Xue, Z.; 
Burrell, A. K.; Curtiss, L. A.; Zhang, L. Adv. Energy 
Mater. 2015, 5, n/a-n/a. 
7. Wei, X.; Xu, W.; Vijayakumar, M.; Cosimbescu, L.; Liu, 
T.; Sprenkle, V.; Wang, W. Adv. Mater. 2014, 26, 7649-
7653. 
8. Casselman, M. D.; Kaur, A. P.; Narayana, K. A.; Elliott, 
C. F.; Risko, C.; Odom, S. A. Phys. Chem. Chem. Phys. 
2015, 17, 6905-6912. 
9. Kaur, A. P.; Holubowitch, N. E.; Ergun, S.; Elliott, C. F.; 
Odom, S. A. Energy Technol. 2015, 3, 476-480. 
10. Odom, S. A.;* Ergun, S.; Poudel, P. P.; Parkin, S. R. 
Energy and Environmental Sciences, 2014, 7, 760-767. 
DOI: 10.1039/C3EE42305K. 
11. Kaur, A. P.; C. F.; Ergun, S.; Odom, S. A.,* Journal of 
the Electrochemical Society, 2016, 163, Al-A7. DOI: 
10.1149/2.0951514jes 
It will be understood that various details of the presently 
disclosed subject matter can be changed without departing 
from the scope of the subject matter disclosed herein. 
Furthermore, the foregoing description is for the purpose of 
illustration only, and not for the purpose of limitation. 
We claim: 
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2. The non-aqueous flow-battery, comprising: 
a negative electrode immersed in a first non-aqueous 
liquid electrolyte solution; 
a positive electrode immersed in a second non-aqueous 
liquid electrolyte solution, the second non-aqueous 
liquid electrolyte solution including at least one com-
pound according to claim 1; and 
a semi-permeable separator interposed between the nega-
tive and positive electrodes. 
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